{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:11:57Z","timestamp":1777349517425,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.anai.2020.12.008","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T15:48:45Z","timestamp":1612021725000},"page":"593-595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Outcomes of 3 patients with adenosine deaminase deficiency on long-term enzyme replacement therapy"],"prefix":"10.1016","volume":"126","author":[{"given":"Melissa D.","family":"Gans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Shliozberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatyana","family":"Gavrilova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arye","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.anai.2020.12.008_bib1","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2018.08.024","article-title":"Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency","volume":"143","author":"Kohn","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2020.12.008_bib2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s10875-017-0421-7","article-title":"Long-term outcome of adenosine deaminase-deficient patients\u2014a single-center experience","volume":"37","author":"Scott","year":"2017","journal-title":"J\u00a0Clin Immunol"},{"issue":"4","key":"10.1016\/j.anai.2020.12.008_bib3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s10875-018-0496-9","article-title":"ADA deficiency: evaluation of the clinical and laboratory features and the outcome","volume":"38","author":"Cagdas","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"issue":"4999","key":"10.1016\/j.anai.2020.12.008_bib4","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1126\/science.1848369","article-title":"An in\u00a0vivo model of somatic cell gene therapy for human severe combined immunodeficiency","volume":"251","author":"Ferrari","year":"1991","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.anai.2020.12.008_bib5","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood-2009-06-189209","article-title":"How I treat ADA deficiency","volume":"114","author":"Gaspar","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.anai.2020.12.008_bib6","doi-asserted-by":"crossref","first-page":"108321","DOI":"10.1016\/j.clim.2019.108321","article-title":"Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy","volume":"211","author":"Grunebaum","year":"2020","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2020.12.008_bib7","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2169","article-title":"A\u00a024-year enzyme replacement therapy in an adenosine-deaminase-deficient patient","volume":"137","author":"Tartibi","year":"2016","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.anai.2020.12.008_bib8","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s10875-020-00857-9","article-title":"Adenosine deaminase (ADA)-deficient severe combined immune deficiency (SCID) in the US Immunodeficiency Network (USIDNet) registry","volume":"40","author":"Kuo","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2020.12.008_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM197902223000802","article-title":"In\u00a0vivo and in\u00a0vitro effects of thymosin and adenosine deaminase on adenosine-deaminase-deficient lymphocytes","volume":"300","author":"Rubinstein","year":"1979","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.anai.2020.12.008_bib10","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI109725","article-title":"Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child","volume":"65","author":"Hirschhorn","year":"1980","journal-title":"J\u00a0Clin Invest"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120620312461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120620312461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:26:24Z","timestamp":1761053184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120620312461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1081120620312461"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2020.12.008","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of 3 patients with adenosine deaminase deficiency on long-term enzyme replacement therapy","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2020.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}